City

New York (2)

Evanston (1)

Los Angeles (1)

Saint Louis (1)

Condition

Leiomyosarcoma (2)

Malignant Fibrous (2)

Sarcoma (2)

Angiosarcoma (1)

Histiocytoma (1)

Histiocytoma/Undifferentiated Pleomorphic Sarcoma (1)

Malignant Peripheral Nerve Sheath Tumor (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Memorial Sloan Kettering Cancer Center (2)

Collaborator

Genentech, Inc. (1)

National Comprehensive Cancer Network (1)

Northwestern University (1)

University of California, Los Angeles (1)

Washington University School of Medicine (1)

Intervention

bevacizumab (1)

docetaxel (1)

gemcitabine (1)

pazopanib 400 mg qd - gemcitabine and docetaxel in combination (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

malignant fibrous

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Sarcoma, Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor Trial in United States (Pazopanib 400 mg QD - Gemcitabine and

Terminated

Has Results

Sarcoma
+4 more

Pazopanib 400 mg QD - Gemcitabine and Docetaxel in Combination

Los Angeles, California
+3 more

Dec 11, 2017

Sarcoma, Leiomyosarcoma, Malignant Fibrous Trial in New York (gemcitabine, docetaxel, bevacizumab)

Completed

Has Results

Sarcoma
+4 more

gemcitabine
+2 more

New York, New York

Memorial Sloan-Kettering Cancer Center

Dec 21, 2015